Genedata Expands AI Discovery Workflows with NVIDIA BioNeMo Open Models, Including the New RFD4-Proteina Release
Bringing next-generation binder design models into production discovery BASEL, Switzerland, Oct. 22, 2026 /PRNewswire/ -- Genedata, a Danaher company, and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the addition of the new RFD4-Proteina...
Covered in this story
Analyst targets on Danaher Corporation
- UBS: $205 → $250 by Sep 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $DHR yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Danaher Corporation →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.